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Cytosolic viral RNA recognition by the helicases
RIG-I and MDA5 is considered the major pathway
for IFN-a/b induction in response to RNA viruses.
However, other cytoplasmic RNA sensors, including
the double-stranded RNA-binding protein kinase R
(PKR), have been implicated in IFN-a/b production,
although their relative contribution and mechanism
have been unclear. Using cells expressing nonfunc-
tional PKR or reduced levels of kinase, we show
that PKR is required for production of IFN-a/b
proteins in response to a subset of RNA viruses
including encephalomyocarditis, Theiler’s murine
encephalomyelitis, and Semliki Forest virus, but not
influenza or Sendai virus. Surprisingly, although
IFN-a/b mRNA induction is largely normal in PKR-
deficient cells, much of that mRNA lacks the poly(A)
tail, indicating that its integrity is compromised. Our
results suggest that PKR plays a nonredundant role in
IFN-a/b production in response to some but not all
viruses, in part by regulating IFN-a/bmRNA stability.
INTRODUCTION
Immunity to viral infection is characterized by the production of
antiviral cytokines, in particular type I interferons (IFN-a/b), which
induce innate antiviral resistance and contribute to adaptive
immunity (Le Bon and Tough, 2002; Samuel, 2001; Stark et al.,
1998). IFN-a/b is primarily induced following the recognition of
viral nucleic acids by host pattern recognition receptors (PRRs)
that survey the extra- and intracellular milieu for the presence
of viral genomes or viral replication intermediates (Pichlmair
and Reis e Sousa, 2007; Takeuchi and Akira, 2008). For instance,
several members of the toll-like receptor (TLR) family, including
TLR3, TLR7, and TLR9, access the endosomal compartment,354 Cell Host & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier Inwhere they are triggered by viral double-stranded (ds) RNA,
single-stranded RNA, and DNA, respectively, entering the cell
from the extracellular milieu (Pichlmair and Reis e Sousa, 2007;
Uematsu and Akira, 2007). In addition, all cells can respond to
the presence of viral nucleic acids that have accessed the cyto-
plasm. The cytosolic PRRs involved in this process have not
been fully identified, but recently the RNA helicases retinoic
acid inducible gene I (RIG-I) and melanoma differentiation-asso-
ciated factor-5 (MDA5) were shown to be essential for recogni-
tion of RNA viruses (Gitlin et al., 2006; Kato et al., 2005; Kato
et al., 2006; Yoneyama et al., 2004). After binding to agonistic
RNAs, both RIG-I and MDA5 interact with the adaptor IPS-1/
MAVS/VISA/Cardif and initiate a signaling cascade that leads
to activation of the transcription factors IRF-3 and IRF-7, which
control transcription of the IFN-a and IFN-b genes (Pichlmair
and Reis e Sousa, 2007; Takeuchi and Akira, 2008). Although
both RIG-I and MDA5 can mediate responses to the synthetic
dsRNA analog poly(I:C) in vitro, analysis of mice deficient for
MDA5 has shown that this helicase is critical for responses to
picornaviruses such as encephalomyocarditis virus (EMCV)
and Theiler’s murine encephalomyelitis virus (TMEV), whereas
RIG-I mediates responses to other RNA viruses including
Newcastle disease virus (NDV), vesicular stomatitis virus (VSV),
Sendai virus (SeV), and influenza virus (Gitlin et al., 2006; Kato
et al., 2005, 2006). This has led to the hypothesis that MDA5
and RIG-I have different specificities and discriminate between
virus-specific forms of viral RNA. Consistent with that notion,
we and others have recently shown that RIG-I but not MDA-5
triggering can ensue from recognition of 50 triphosphate groups
present in the genomes of many RNA viruses (Habjan et al.,
2008; Hornung et al., 2006; Pichlmair et al., 2006; Rehwinkel
et al., 2010). RNA agonists for MDA-5 have not been fully charac-
terized but are thought to correspond to long molecules of
dsRNA.
dsRNA can be found in the genome of some viruses but can
also be generated during the process of viral replication. Inter-
estingly, immunodetectable dsRNA (i.e., dsRNA >30 bp) is
seen primarily in cells infected with DNA or positive-strand
RNA viruses (Pichlmair et al., 2006; Weber et al., 2006), manyc.
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Figure 1. PKR Is Required for IFN-a/b Production by BM-DCs
in Response to EMCV, TMEV, and SFV
BM-DCs (5 3 105/well) were infected with RNA viruses as indicated, and
IFN-a/b accumulation in the culture supernatants was measured by ELISA
after overnight culture. Data are the mean ± SD of triplicate wells.
(A) Production of IFN-b protein (left panel) and IFN-a protein (right panel)
by BM-DCs infected with EMCV (moi = 10) or influenza virus (Flu [DNS1])
(moi = 1). Data are representative of at least three (influenza virus) and ten
(EMCV) independent experiments.
(B) Production of IFN-b protein (left panel) and IFN-a protein (right panel) by
BM-DCs infected with TMEV(DL) (moi = 10) or SeV (moi = 1). Data are repre-
sentative of at least three (TMEV) and ten (SeV) independent experiments.
(C) IFN-a/b production in response to SFV is mainly dependent on MDA5.
BM-DCs lacking either MDA5, RIG-I, or PKR were infected with SFV
(moi = 10). Data shown are one out of two experiments with similar results.
(D) IFN-a production in relation to infectious dose for EMCV (left panel) and SeV
(right panel). Data represent one of two experiments with similar results.
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PKR Regulates IFN-a/b Protein Synthesisof which are recognized by MDA5. Such dsRNA also binds to
and activates PKR, an enzyme that confers antiviral resistance
but differs structurally and functionally from the RNA helicases
(Williams, 1999, 2001). PKR belongs to the family of kinases
that regulate cellular functions in response to stress and viral
infection (Holcik and Sonenberg, 2005). The main function of
PKR is to limit viral replication through phosphorylation of
the a subunit of the translation initiation factor eIF-2, which
results in shutdown of cellular and viral protein synthesis
(Williams, 1999, 2001). Long before the discovery of MDA5 and
RIG-I, PKR was proposed to act as a virus PRR involved in
type I IFN induction. Some studies, including our own, found
that PKR-deficient cells can be defective in IFN-a/b production
in response to poly(I:C) (Diebold et al., 2003; McAllister and
Samuel, 2009; Smith et al., 2001; Yang et al., 1995). However,
PKR deficiency did not prevent IFN-a/b responses to NDV and,
in some cases, IFN-a/b production could be restored in PKR/
cells by pretreatment with type I IFN (Yang et al., 1995). The
subsequent discovery of RIG-I and MDA5 led to the conclusion
that PKR is largely unimportant for IFN-a/b induction (Pichlmair
and Reis e Sousa, 2007; Takeuchi and Akira, 2008). However,
some recent studies support a nonredundant role for the kinase
in IFN-a/b responses to viral infection (Barry et al., 2009;
Carpentier et al., 2007; Gilfoy and Mason, 2007) and raise the
possibility that some but not all viruses induce IFN-a/b in a
PKR-dependent manner.
Here we report that PKR is required for IFN-a/b production in
response to a specific subset of RNA viruses including EMCV,
TMEV, and Semliki Forest virus (SFV). Surprisingly, unlike RIG-I
and MDA5, PKR does not act by inducing IFN-a/b gene
transcription but rather by indirectly maintaining the integrity of
newly synthesized IFN-a/bmRNA, thereby permitting its transla-
tion. Our data reveal a key and nonredundant role for PKR in
sustaining the IFN response to some RNA viruses and help
reconcile apparently conflicting observations in the literature
on the role of PKR in type I IFN induction.
RESULTS
PKR Requirement for IFN-a/b Production Is Virus
Specific
We re-examined the role of PKR in IFN production by infecting
wild-type or PKR-deficient mouse bone marrow-derived den-
dritic cells (BM-DCs) in vitro with a panel of RNA viruses that
are sensed primarily by MDA5, including EMCV, TMEV, or
viruses that are recognized by RIG-I such as influenza virus
and SeV. Production of IFN-a/b by PKR-deficient BM-DC was
normal in response to wild-type or DNS1 influenza virus (influ-
enza mutant lacking the interferon inhibitor NS1; Figure 1A and
data not shown) or SeV (Figure 1B), as measured by IFN-a and
IFN-b protein accumulation in culture supernatants. In contrast,
EMCV and TMEV(DL), a TMEV mutant lacking the interferon
antagonistic leader (L) protein, failed to induce measurable levels
of IFN-a or IFN-b protein in the absence of PKR (Figures 1A and
1B). Like EMCV and TMEV, alphaviruses such as SFV generate
considerable amounts of dsRNA in infected cells (see Figure S1A
available online). IFN-a/b production in response to SFV was
barely detectable in the absence of MDA5 and was reduced by
4-fold in RIG-I/ BM-DCs (Figure 1C), indicating that SFV isCellrecognized by MDA5 with a modest contribution from RIG-I
(see also Figure 4). Importantly, IFN-a and IFN-b production after
infection with SFV was also reduced by more than 100-fold in
BM-DC lacking PKR (Figure 1C). IFN-a/b induction by EMCV
but not SeV was PKR dependent at all doses testedHost & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier Inc. 355
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Figure 2. PKR Mediates IFN-a/b Production by MEFs in Response
to EMCV
Immortalized MEFs (53 105/well) were stimulated with IFN A/D (1000 U/ml) for
2 hr prior to infection with EMCV or SeV. IFN-a/b accumulation in the culture
supernatants was measured by ELISA after overnight culture. Data are the
mean ± SD of triplicate wells.
(A) IFN-b protein (left panel) and IFN-a protein (right panel) from PKR/ and
wild-type MEFs infected with EMCV (moi = 10) or SeV (moi = 1).
(B) IFN-b protein (left panel) and IFN-a protein (right panel) from siRNA-treated
MEFs after infection with EMCV or SeV (moi = 1). Data are representative of
four independent experiments.
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PKR Regulates IFN-a/b Protein Synthesis(Figure 1D), indicating that the virus-specific PKR dependence
was not merely a quantitative effect.
We measured dsRNA content as well as cell viability after viral
infection. The percentage of cells expressing dsRNA following
infection with EMCV or SFV was higher for PKR-deficient than
for wild-type BM-DC (Figure S1A), in line with the established
role of PKR in suppressing viral replication (Williams, 1999,
2001). We found a slight increase in the percentage of dead cells
in cultures of BM-DC lacking PKR (Figure S1B), although this
effect was too small to account for the lack of IFN-a/b secretion
by these cells. Thus, lack of virus replication or cell death cannot
explain the impaired IFN-a/b responses in PKR-deficient DCs
infected with picornaviruses or SFV.
To confirm these observations in another cell type, we
analyzed IFN-a/b expression in MEFs. To circumvent virus-
induced cytotoxicity in those cells, which was much more
pronounced than in DCs (data not shown), MEFs were pre-
treated with IFN-a/b. We used IFN A/D, a human IFN hybrid
that does not cross-react with the ELISA antibodies used for
measuring mouse IFN-a/b but acts like other IFNs to promote
an antiviral state that protects the cells from cytopathic effects
of viral infection (Rehberg et al., 1982). Like DCs, PKR/
MEFs treated with IFN A/D mounted a normal IFN-a/b response
after SeV infection but showed a severe defect in the response to
EMCV (Figure 2A). We also used siRNA-mediated gene silencing
to rule out that the effect was due to a secondary phenotype of
the PKR-deficient cells. When infected with EMCV, MEFs treated
with PKR-specific siRNA showed a 3-fold reduction in PKR
levels (data not shown) and a 60% reduction in the level of
IFN-a and IFN-b compared to MEFs treated with a control siRNA
(Figure 2B). Consistent with the results in PKR-deficient cells, the
PKR-specific siRNA did not impair the response to SeV (Fig-
ure 2B). Altogether, these observations suggest that PKR is
required for IFN-a/b production in response to some RNA viruses
and that the PKR dependence of the IFN-a/b response to any
given virus correlates with reliance on the MDA5 pathway.
Phosphorylation of eIF-2a Is Not Necessary for IFN-a/b
Production in Response to PKR-Dependent Viruses
Most biological effects of PKR are mediated through phosphor-
ylation of eIF-2a (Holcik and Sonenberg, 2005; Williams, 1999,
2001). To test whether eIF-2a phosphorylation is required for
the PKR-dependent production of IFN-a/b in response to
EMCV and SFV, we used cells with a homozygous Ser-to-Ala
mutation at the eIF-2a phosphorylation site (Ser51) (Scheuner
et al., 2001). In contrast to wild-type cells, eIF-2a mutant
MEFs (eIF2A/A) did not phosphorylate eIF-2a in response to
poly(I:C) (Figure 3A). Nevertheless, eIF2A/A MEFs showed no
defect in their ability to produce IFN-a or IFN-b proteins in
response to stimulation with poly(I:C) (data not shown) or upon
infection with EMCV or SFV (Figure 3B). We conclude that phos-
phorylation of eIF-2a is not required for PKR-dependent IFN-a/b
production.
PKR Regulates IFN-b mRNA Integrity Rather Than
Transcriptional Activation in Cells Infected with EMCV
We next asked whether PKR is necessary for EMCV- or SFV-
dependent transcriptional induction of the IFN-a/b genes.
Because the IFN-a ELISA detects multiple IFN-a subtypes, we356 Cell Host & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier Infocused on IFN-b, which is encoded by a single gene, allowing
us to directly correlate the protein and transcript levels. The latter
were determined by quantitative PCR of cDNA generated by
random hexamer oligonucleotide priming of RNA extracted
from infected cells. As expected (Kato et al., 2005, 2006), SeV
infection induced the appearance of IFN-b mRNA in a RIG-I-
dependent, MDA-5-independent manner, which correlated
with IFN-b protein expression (Figures 4A and 4B). Consistent
with the role of MDA5 as a PRR for SFV and EMCV, MDA5/
cells failed to accumulate IFN-b mRNA or produce IFN-b protein
in response to either virus (Figures 4A and 4B). In contrast, to our
surprise, IFN-b mRNA was induced >1000-fold in PKR-deficient
cells infected with EMCV (Figure 4B) even though IFN-b protein
was not detectable (Figure 4A). Similarly, infection with SFV
led to upregulation of IFN-b mRNA in PKR/ DCs at levels
100-fold and 10-fold higher than in DCs lacking either MDA5 or
RIG-I, respectively (Figure 4B), but did not result in IFN-b protein
production (Figure 4A). Taken together, our data suggest that,
although MDA5 and PKR are both essential for driving IFN-a/b
production in response to EMCV and SFV, the mechanism of
their action is different. Unlike MDA5, PKR is largely dispensable
for the induction of IFN-a/b mRNA but appears to act posttran-
scriptionally to regulate protein production.
It was intriguing that PKR/ cells produced little IFN-b protein
despite seemingly normal induction of IFN-b mRNA following
infection with EMCV. To gain further insight into this issue, we
analyzed IFN-b mRNA from EMCV-infected cells by northern
blot. This analysis indicated that IFN-b mRNA levels were in
fact 6- to 8-fold lower in PKR/ BM-DC compared to PKR+/+c.
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Figure 3. Phosphorylation of eIF-2a Is Not
Necessary for IFN-a/b Production in
Response to PKR-Dependent Viruses
(A) Confocal analysis of eIF-2a phosphorylation in
Ser51 mutant MEFs (eIF2A/A) and control MEFs.
Cells were stimulated with poly(I:C) for 6 hr and
stained with mAbs specific for phospho-eIF-2a
and dsRNA (K1), as well as the nuclear dye
DRAQ5. Phospho-eIF-2a and dsRNA staining are
shown in green and red, respectively.
(B) IFN-b protein (left panel) and IFN-a protein
(right panel) from eIF-2A/A and control eIF-2S/S
MEFs infected with EMCV (moi = 10), SFV
(moi = 10), or SeV (moi = 1). Data shown are from
one out of three experiments, and represent
mean ± SD.
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PKR Regulates IFN-a/b Protein Synthesiscells (Figures 5A and 5B). It was conceivable that the lower IFN-b
mRNA levels in PKR-deficient cells arose from a failure to up-
regulate MDA5, which is itself IFN inducible (Kang et al., 2002).
Consistent with this notion, PKR/ cells showed decreased
levels of MDA5 mRNA upon infection with EMCV but not SeV,
which could be corrected by pretreatment with IFN-A/D
(Figure S2). Notably, IFN A/D pretreatment also restored IFN-
b mRNA levels in EMCV-infected PKR-deficient DC to within
1- to 3-fold of the levels in wild-type cells (Figure 5B). However,
IFN A/D pretreatment failed to rescue IFN-b protein production
by DC (Figure 5C), as noted for MEFs (see above).
Unexpectedly, northern blot analysis of RNA from cells in-
fected with EMCV revealed the presence of two bands for IFN-
b with different apparent molecular sizes (Figures 5A and 5B).
The lower molecular size band was especially prominent in
PKR-deficient cells: it accounted for 10%–20% of the total
IFN-b mRNA in PKR+/+ DC but up to 60% in PKR/ DC (Figures
5A, 5B, and 5D). The shorter form of IFN-b mRNA was not seen
upon infection with SeV and was not especially prominent in
response to transfection with poly(I:C) (Figures 5A, 5B, and
5D). The size difference between the short and long forms was
a few hundred bases, which could correspond to the poly(A)
tract of the mRNA. Consistent with that notion, the shorter
form had an apparent molecular size of around 750 bases
(Figures 5A and 5B), similar to that reported for the IFN-
b cDNA lacking the poly(A) tail (Higashi et al., 1983). To test the
possibility that the lower molecular size band corresponded to
IFN-b mRNA lacking a poly(A) tail, we hybridized dT oligonucle-
otides to RNA from infected cells and digested with RNase H.
After enzymatic removal of the poly(A) tail, all IFN-b mRNA
showed an electrophoretic mobility similar to that of the lower
band seen in RNA from PKR/ cells not treated with RNase HCell Host & Microbe 7, 354–(Figure 5D). Importantly, the mRNA from
EMCV-infected PKR/ cells did not
show a further shift in electrophoretic
mobility, indicating that it was already
deadenylated (Figure 5D). Furthermore,
when dT oligonucleotides were used
instead of random hexamer oligonucleo-
tides to generate complementary DNA,
quantitative PCR revealed a profound
difference in the levels of IFN-b mRNAbetween PKR+/+ and PKR/ cells (Figure 5E). This effect was
EMCV specific, because we found no difference between hex-
amer and oligo dT-primed IFN-b cDNA in cells infected with
SeV (Figure 5E), consistent with the northern blot analysis
(Figures 5B and 5D). We also compared hexamer and oligo
dT-primed cDNA for several other inducible or constitutively
expressed genes, including GAPDH, IL-6, TNF-a, and RPS-16,
and observed that the ratio of cDNA between wild-type and
PKR/ cells following infection with EMCV or SeV remained
unchanged (Figure S3). These results indicate that the lack of
a poly(A) tail in EMCV-infected cells is specific to IFN-b mRNA
and not reflective of a generic deadenylation of all cellular
mRNAs. We conclude that, in the absence of PKR, most of the
IFN-b mRNA generated in response to EMCV infection lacks
the poly(A) tail. This could impair its translation and explain
the absence of IFN-b protein synthesis by EMCV-infected
PKR/ cells.
Serum Levels of IFN-b Are Reduced in PKR-Deficient
Mice after Infection with EMCV
To extend these observations to an in vivo setting, we infected
wild-type and PKR-deficient mice with EMCV and measured
IFN-b in the serum at 20 hr postinfection. Serum IFN-b levels in
wild-type mice were generally low regardless of genetic back-
ground (Figures 6A–6C), and mRNA for IFN-b in tissues was
below the detection limit, precluding analysis of its adenylation
status (data not shown). Nevertheless, we consistently observed
even lower levels of serum IFN-b protein in mice lacking PKR
(Figures 6A–6C). This was true in experiments when wild-type
129/Sv mice were compared to PKR/ mouse on a mixed 129
Sv/C57BL/6 background (Figure 6A) but also when PKR/
mice that had been backcrossed more than ten times to the361, May 20, 2010 ª2010 Elsevier Inc. 357
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Figure 4. PKR Deficiency Disproportionately Reduces IFN-b Protein
versus mRNA
BM-DCs (5 3 105/well) were infected with RNA viruses for 12 hr as indicated.
IFN-b protein in the culture supernatants and IFN-b mRNA in total cDNA from
lysed cells (synthesized using random hexamer primers) were measured by
ELISA and quantitative PCR, respectively. Data are the mean ± SD of triplicate
wells. (A) Production of IFN-b protein and (B) IFN-b mRNA from DCs lacking
MDA5, RIG-I, or PKR following infection with EMCV (moi = 10), SFV (moi = 10),
or SeV (moi = 1). Data are representative of two independent experiments with
similar results.
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PKR Regulates IFN-a/b Protein SynthesisC57BL/6 strain were compared to wild-type mice of that strain
(Figure 6B). Finally, PKR deficiency led to a reduction in serum
IFN-b levels in MyD88/ mice infected with EMCV (Figure 6C),
excluding the possibility that the effect of PKR was downstream
of the TLR7 pathway, which can contribute to IFN responses to
ssRNA viruses in vivo. In conclusion, our results and those of
others (Barry et al., 2009) confirm a role for PKR in generating
an optimal IFN response to EMCV and SFV in vivo.DISCUSSION
The notion that PKR is involved in the induction of IFN-a/b has
largely been dismissed by the discovery of the RNA helicasesC
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358 Cell Host & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier InRIG-I and MDA5 and associated signaling pathways (Pichlmair
and Reis e Sousa, 2007; Takeuchi and Akira, 2008). RNA viruses
are increasingly classified by their ability to stimulate RIG-I,
MDA5 or a combination of both (Gitlin et al., 2006; Kato et al.,
2005;, 2006). Here, we compared viruses representing different
ends of this spectrum for their ability to induce IFN-a/b in the
absence or presence of PKR. In agreement with previous studies
using NDV (Smith et al., 2001; Yang et al., 1995), PKR was not
required for IFN-a/b production in cells infected with RIG-I-
dependent viruses such as influenza and SeV. In contrast, IFN-
a/b production in response to the picornaviruses EMCV and
TMEV, both capable of triggering MDA5, was greatly reduced
in cells lacking PKR. Furthermore, SFV, which we find to be
primarily recognized via MDA5, also required PKR for IFN protein
production, as reported recently (Barry et al., 2009). Two
previous reports have also implicated PKR in cytokine produc-
tion after infection with TMEV and West Nile virus (Carpentier
et al., 2007; Gilfoy and Mason, 2007), two viruses that are recog-
nized, at least in part, via MDA5 (Fredericksen et al., 2008). Thus,
it is intriguing to speculate that PKR may promote IFN-a/b
production to MDA5- but not to RIG-I-dependent viruses. Inter-
estingly, a requirement for PKR in IFN-a/b responses to the puta-
tive MDA5 agonist, poly(I:C), had been noted in some studies
(Diebold et al., 2003; McAllister and Samuel, 2009; Smith et al.,
2001; Yang et al., 1995). We find that such PKR dependence is
variable, perhaps because many preparations of poly(I:C) addi-
tionally stimulate RIG-I and TLR3 pathways, and is therefore
best observed using viruses that show a strong dependence
on MDA5 for IFN-a/b induction (O.S., A.P., and C.R.S., unpub-
lished data). The correlation between MDA5 and PKR depen-
dence of antiviral IFN-a/b responses may arise from the fact
that PKR and MDA5 can be activated by long dsRNA (Lemaire
et al., 2008), which is not produced to any great extent by IFN A/D + IFN A/D
WT
pkr-/-
SeV
Figure 5. Deadenylated IFN-b mRNA in
EMCV-Infected PKR/ Cells
(A–C) BM-DCs (53 105/well) were transfected with
poly(I:C) (10 mg/well) for 6 hr or infected with EMCV
(moi = 10) for 9 hr in the absence or presence of
IFN A/D (1000 U/ml) as indicated. (A and B) IFN-b
mRNA was analyzed by northern blot, and the
position of two distinct species of IFN-b mRNA is
indicated by arrowheads. The size of the different
mRNA species was calculated by comparing their
electrophoretic mobility to a molecular size marker
in the form of a ssRNA ladder. Numbers below
picture represent fold difference between samples
from PKR+/+ and PKR/ cells as determined by
phosphoimager analysis. (C) IFN-b protein in the
supernatant from the same cultures as in (B) was
measured by ELISA. Data are the mean ± SD of
triplicate wells and are representative of three
independent experiments with similar results.
(D) Detection of polyA+ and polyA forms of IFN-b
mRNA by northern blot. Total RNA was isolated
from BM-DCs infected with EMCV (moi = 10) or
re treated with oligo-dT ± RNase H. Arrowheads indicate position of polyA+
om hexamer (open bars) or oligo dT oligonucleotides (filled bars) to generate
lculated by analyzing the Ct values for each amplification curve and converting
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Figure 6. PKR Promotes IFN-b Protein Production in Response
to Infection with EMCV In Vivo
IFN-b protein was measured in the serum of mice that had been infected with
EMCV 20 hr earlier.
(A) Wild-type (129 Sv) and PKR/ mice (mixed 129 Sv/C57BL/6 background),
p < 0.006 (n = 10).
(B) Wild-type (C57BL/6) and PKR/ mice (C57BL/6 background), p < 0.008
(n = 5).
(C) MyD88/ and MyD88/ 3 PKR/ mice, p < 0.03 (n = 4).
(A–C) Dots represent individual mice, bars are mean ± SD. Data in each panel
are representative of two independent experiments with similar results. Paired
data were analyzed using a two-tailed Mann-Whitney test.
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PKR Regulates IFN-a/b Protein Synthesismany of the RIG-I-dependent viruses (Pichlmair et al., 2006;
Weber et al., 2006). However, it should be noted that PKR can
also be activated upon infection with RIG-I-dependent viruses,
possibly through 50-triphosphate RNA containing short stem
loops (Nallagatla et al., 2007). Therefore, one would need to
envisage that different RNA agonists elicit different PKR
responses and that PKR has a hitherto unappreciated role in
controlling IFN-a/b production when it has been activated by
infection with viruses that generate specific forms of dsRNA.
EMCV has emerged as the prototypic MDA5-dependent virus
(Gitlin et al., 2006; Kato et al., 2006), and a previous study
showed a reduction in IFN-a/b expression following EMCV infec-
tion of cells expressing a dominant-negative form of PKR (Der
and Lau, 1995). This is consistent with our findings, although,
in contrast to that earlier report, we could find no evidence that
PKR contributes significantly to the induction of IFN-a/b genes.
Although PKR can promote the activation of nuclear factor
kappa B (Kumar et al., 1994), its ability to activate IRF-3 and -7,
the critical transcription factors in induction of IFN-a/b genes
(Honda and Taniguchi, 2006; Sato et al., 2000), has not been
formally demonstrated. Our data are consistent with the current
concept that signaling via RIG-I-like helicases, but not through
PKR, leads to transcription of the IFN-a and IFN-b genes
(Yoneyama et al., 2005). Nevertheless, our results support
a role for PKR in regulating the quality of IFN-a/b mRNA in the
context of viral infection. How PKR regulates this process or
what are the molecular targets downstream of PKR is currently
not understood. We have been able to rule out a role for the
translation initiation factor eIF-2a, the best-characterized PKR
substrate, by showing that phosphorylation of eIF-2a is not
required for IFN production in response to EMCV infection. Given
that eIF-2a phosphorylation is crucial for the virus-induced trans-
lation stop (Garcia et al., 2006) and apoptosis (Kaufman, 1999;
Scheuner et al., 2006), these results indicate that PKR promotes
IFN-a/b protein expression by a different mechanism.
This mechanism appears to involve regulation of IFN-a/b
mRNA integrity, as we found that much of the IFN-b mRNA
from PKR/ cells after infection with EMCV appears truncated.
Any role for PKR in preventing this process is not only specific toCellinfection with some viruses but also mRNA specific, as we did
not observe loss of integrity in other mRNAs, be they from induc-
ible or constitutively expressed genes. Further analysis of IFN-b
mRNA from EMCV-infected cells suggests that the truncated
form of IFN-b mRNA might correspond to mRNA that has lost its
poly(A) tail. The expression of many cytokines is controlled by
posttranscriptional mechanisms that regulate various aspects
of RNA biology, especially mRNA stability and decay (Anderson,
2008). Indeed, IFN-b mRNA contains several destabilizing
elements, including a class II AU-rich element that promotes
asynchronous deadenylation and leads to the accumulation of
poly(A)-negative intermediates (Paste et al., 2003). The mole-
cules that bind to the destabilizing elements in IFN-b mRNA or
that regulate the degradation of the poly(A) tail remain poorly
characterized (Anderson, 2008; Raj and Pitha, 1993) and, there-
fore, leave open many possibilities as to how PKR regulates
IFN-b mRNA integrity in the context of EMCV infection. For
example, PKR impacts on eIF4E phosphorylation via the B56a
regulatory subunit of protein phosphatase 2A, thereby poten-
tially affecting translation and deadenylation of mRNA in a
manner independent of eIF2a (Xu and Williams, 2000). Alterna-
tively, PKR may act by antagonizing virus-specific factors that
promote destabilization of IFN-b mRNA rather than having
a direct role in regulating IFN-a/b mRNAs. Although we do not
understand the mechanism at present, our data nevertheless
provide a possible explanation as to why IFN-b mRNA, despite
being present in PKR/ cells, is not expressed at the protein
level.
In sum, our data support a role for PKR in regulating the
expression of IFN-a/b proteins and demonstrate that PKR is
required coordinately with a member of the RIG-I-like helicase
family, MDA5, to induce an IFN response to certain RNA viruses.
Our study further reveals that PKR may act primarily in establish-
ing and/or maintaining the polyadenylation status of IFN-a/
b mRNA, adding to our understanding of IFN-a/b induction after
virus infection and revealing a hitherto unappreciated role for
mRNA stability in the process.
EXPERIMENTAL PROCEDURES
Reagents
IFN A/D was a gift from I. Kerr (Cancer Research UK). Poly(I:C) was from
Amersham Biosciences. Recombinant murine GM-CSF was made at Cancer
Research UK. SiRNA specific for mouse PKR (Prkr-3) and human PRMT
(protein arginine methyltransferase; control siRNA) were from QIAGEN. The
target sequences for murine PKR and human PRMT are CAGCTCGTCTATGA
CAAGTAA and AAAGATTACTACTTTGACTCC, respectively. Anti-dsRNA anti-
body (clone K1) was from English & Scientific Consulting Bt. Polyclonal anti-
phospho-eIF-2a (Ser51) was from New England Biolabs.
The plasmid pGEM-IFN-bwas generated by PCR amplification of full-length
IFN-b from BM-DCs stimulated with SeV and subsequent cloning of the PCR
product into pGEM-T vector (Promega). The sequences for murine IFN-b
forward and reverse primers were 50-ATGAACAACAGGTGGATCC and 50-GG
CATCAACTGACAGGTCTT, respectively.
The plasmid pBABE-puro-LargeT was a gift from G. Peters (Cancer
Research UK).
Animals and Cells
Strain 129 SvEv mice were obtained from Taconic. PKR/ mice (Yang et al.,
1995) on a mixed 129 SvEv x C57Bl6 background were originally obtained from
H. Unger (University of Veterinary Medicine, Vienna, Austria) and were main-
tained in the animal facility of CRUK (Clare Hall, South Mimms, UK) underHost & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier Inc. 359
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PKR Regulates IFN-a/b Protein Synthesisspecific pathogen-free conditions. For in vivo experiments, mice were fully
backcrossed (ten generations) to C57BL/6 or to mice deficient in MyD88.
BM-DCs were generated in RPMI 1640 medium containing 10% FCS, 2 mM
glutamine, 50 mM 2-mercaptoethanol, 100 units/ml penicillin, 100 mg/ml strep-
tomycin, and GM-CSF (10-ng/ml). Wild-type (129-SvEv Tac) and PKR/
MEFs were prepared from 12.5 day embryos by standard protocols. MEFs
were used as primary cells or after immortalization with retrovirus expressing
large T antigen prepared from supernatants of Phoenix cells transfected with
pBABE-puro-LargeT. Immortalized MEFs were selected on puromycin (final
concentration 2 mg/ml) for 2 weeks and were grown in DMEM medium contain-
ing 10% FCS, 2 mM glutamine, 100 units/ml penicillin, and 100 mg/ml strepto-
mycin. Primary MEFs were grown in DMEM containing 10% filtered, non-heat-
inactivated FCS, 13MEM amino acids, 13 non-essential amino acids, 50 mM
2-mercaptoethanol, 100 units/ml penicillin, and 100 mg/ml streptomycin.
Viruses and Cytokine Induction Assays
Influenza A/PR/8/34 and DNS1 were a gift from T. Muster (Vienna). SFV and
EMCV were a gift from I. Kerr. TMEV(DL) was a gift from T. Michiels (Brussels).
SeV was obtained from LGC Promochem/ATCC.
BM-DCs or MEFs were seeded in 24 plates at 5 3 105 cells per ml and
cultured with different viruses for 12–15 hr unless indicated otherwise. This
time point was chosen because for some viruses (i.e., EMCV), IFN-a/b protein
became detectable only at around 10 hr after infection (data not shown). IFN
A/D (1000 U/ml) was added to MEF cultures 2 hr prior to infection. Mice were
infected intravenously with EMCV (106 pfu/mouse). Supernatants or mouse
sera were assayed for cytokine content by sandwich ELISA. IFN-a (multiple
subtypes) was measured by ELISA as described previously (Diebold et al.,
2003), and IFN-b was measured using an ELISA Kit (R&D Systems).
Flow Cytometry
BM-DCs were seeded in 24 plates at 5 3 105 cells per ml and infected with
EMCV or SFV overnight. Cells were fixed in 4% paraformaldehyde, permeabi-
lized using 0.1% saponin, and stained with anti-CD11c mAb (Becton Dickin-
son) and anti-dsRNA mAb followed by appropriate secondary antibodies.
For assessment of cell viability, BM-DCs were fixed and stained with LIVE/
DEAD fixable dead cell dye (Invitrogen) as recommended by the manufacturer.
Samples were run on a FACS Calibur (Becton Dickinson), and data were
analyzed using FlowJo software (Treestar).
Confocal Microscopy
MEFs were grown on coverslips overnight and stimulated for 6 hr with dsRNA
by transfecting poly(I:C) (1 mg/well) complexed with Lipofectamine 2000 (Invi-
trogen). Cells were fixed in 4% paraformaldehyde, permeabilized in 0.1%
Triton X-100, and stained with anti-dsRNA and anti-phospho-eIF-2a anti-
bodies followed by secondary antibodies including Alexa 488-conjugated
anti-rabbit, Alexa 546-conjugated anti-mouse, and DRAQ5 (Invitrogen).
Coverslips were mounted on a slide and images taken with a laser-scanning
confocal microscope (LSM 510; Zeiss).
PKR Knockdown
MEFs were seeded at 2.5 3 104 cells/well in 24-well plates in DMEM medium
without antibiotics. Cells were transfected twice (at 0 and +24 hr) with PKR-
specific siRNA or control siRNA (40 pmol/well) using the transfection reagent
Lipofectamine 2000 (Invitrogen). At the end of 48 hr cells were either stimulated
with IFN A/D (1000 U/ml) for 1–2 hr prior to infection with viruses as indicated or
stimulated with IFN A/D (1000 U/ml) alone overnight for analysis of PKR protein
by western blot.
PCR and Northern Blot
Total RNA was isolated from infected or uninfected cells using the RNeasy kit
(QIAGEN) combined with a DNA digestion step (DNase set, QIAGEN). Single-
stranded cDNA was synthesized using SuperScript II (Invitrogen) and random
hexamer or poly dT primers. Quantitative PCR amplification was carried out
using TaqMan universal master mix (Applied Biosystems) and predeveloped
TaqMan assay reagents (containing primers and fluorescent probe) for murine
IFN-b, MDA5, 18 s rRNA, IL-6, TNF-a, RPS-16, and GAPDH (Applied Biosys-
tems) on an ABI 7900HT thermal cycler (Applied Biosystems).360 Cell Host & Microbe 7, 354–361, May 20, 2010 ª2010 Elsevier InFor northern blotting, total RNA was separated by gel electrophoresis on an
1.5% agarose gel. RNA was transfered by capillary action to a nylon
membrane (Hybond-N+; Amersham Biosciences), crosslinked to the
membrane with UV light, and hybridized with [a32P]-dCTP and [a32P]-dATP
(Perkin Elmer) labeled probes. Antisense deoxyribo probes specific for murine
IFN-b were generated by linear PCR amplification of a full-length template
(generated through conventional PCR amplification of pGEM-IFN-b) using
the reverse primer for IFN-b. For poly(A) tail digestion, total RNA was hybrid-
ized to dT(15) oligonucleotides and treated with RNase H (USB Europe
GMBH) for 2 hr at 37C.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article at doi:10.1016/j.chom.2010.04.007.
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